Ivermoh-S 6 Tablet contains Ivermectin 6 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin belongs to the class of macrocyclic lactones and exerts its effect by binding selectively to glutamate-gated chloride ion channels in the nerve and muscle cells of parasites, leading to increased permeability to chloride ions, hyperpolarization, paralysis, and eventual death of the parasite. Ivermoh-S 6 Tablet is indicated for the treatment of onchocerciasis (river blindness), strongyloidiasis, and other susceptible parasitic infestations including scabies and certain lice infestations. The drug is administered orally, with dosage and duration depending on the specific infection and patient factors such as weight and age. It is generally well tolerated, but potential side effects may include dizziness, nausea, diarrhea, and mild skin reactions. Ivermectin is contraindicated in patients with known hypersensitivity to the drug and should be used cautiously in individuals with impaired liver function. It is important to follow the prescribed dosage regimen and consult a healthcare professional before use, especially in pregnant or breastfeeding women. Ivermoh-S 6 Tablet offers an effective therapeutic option for managing parasitic infections, contributing to improved patient outcomes and quality of life.